Maria Alessandra C.
- Country
- Italy
- Department
- U.O.C. Oncologia medica
Research Overview
- Phase 2 Randomized Open‑Label Study of Denikitug Monotherapy and Denikitug‑Based Combination Therapy in Adults with Advanced Microsatellite Stable Colorectal Cancer
- Evaluation of Encorafenib and Cetuximab with FOLFIRI in BRAF V600E Mutated Metastatic Colorectal Cancer Post-Progression on Encorafenib and Cetuximab
Data & Insights
Has run more than one trial at 2 of 19 partner sites.
Specializations
Colorectal Cancer Research
This investigator specializes in the treatment of metastatic colorectal cancer, with particular emphasis on cases involving BRAF V600E mutations.
- Advanced Colorectal Cancer Management
- Targeted Therapy Approaches
- Treatment Resistance Studies
Their research explores therapeutic strategies for patients whose disease has progressed after initial treatment.
Precision Oncology
The investigator focuses on mutation-specific treatment approaches, particularly in the context of targeted therapy combinations for colorectal cancer.
- Molecular Profiling
- Biomarker-Driven Therapy
- Personalized Treatment Strategies
Their work emphasizes the importance of genetic testing in guiding treatment decisions.
Treatment Innovation
The investigator studies combination therapy approaches in advanced colorectal cancer, focusing on improving outcomes for patients with specific genetic profiles.
- Novel Drug Combinations
- Sequential Therapy
- Treatment Optimization
Their research explores innovative treatment sequences in progressive disease scenarios.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.